ConvaTec Group PLC (LON:CTEC – Get Free Report)’s share price rose 0.2% during mid-day trading on Friday . The company traded as high as GBX 244.60 and last traded at GBX 243. Approximately 1,348,906,000 shares traded hands during trading, an increase of 6,441% from the average daily volume of 20,622,102 shares. The stock had previously closed at GBX 242.60.
Analyst Ratings Changes
CTEC has been the topic of a number of recent research reports. Royal Bank Of Canada raised shares of ConvaTec Group to an “outperform” rating and decreased their price target for the company from GBX 320 to GBX 315 in a research note on Thursday, August 21st. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and set a GBX 315 price target on shares of ConvaTec Group in a research note on Wednesday, July 30th. Berenberg Bank decreased their price target on shares of ConvaTec Group from GBX 335 to GBX 330 and set a “buy” rating on the stock in a research note on Tuesday, August 19th. JPMorgan Chase & Co. reaffirmed an “overweight” rating on shares of ConvaTec Group in a research note on Wednesday, July 30th. Finally, Peel Hunt reaffirmed a “buy” rating and set a GBX 280 price target on shares of ConvaTec Group in a research note on Tuesday, October 28th. Five equities research analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, ConvaTec Group presently has a consensus rating of “Buy” and a consensus target price of GBX 309.40.
View Our Latest Research Report on CTEC
ConvaTec Group Trading Up 0.2%
Insider Activity
In related news, insider Karim Bitar sold 1,250,000 shares of the firm’s stock in a transaction dated Thursday, August 7th. The shares were sold at an average price of GBX 227, for a total value of £2,837,500. Also, insider Jonny Mason purchased 50,000 shares of ConvaTec Group stock in a transaction that occurred on Thursday, August 28th. The stock was bought at an average cost of GBX 235 per share, for a total transaction of £117,500. Company insiders own 0.91% of the company’s stock.
About ConvaTec Group
ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns.
Recommended Stories
- Five stocks we like better than ConvaTec Group
 - Industrial Products Stocks Investing
 - Is Beyond Meat a Buy After Meme Stock Surge? Analysts Say No
 - What is the NASDAQ Stock Exchange?
 - ABBV Stock: $250 May Be the New Floor After Big Q3 Earnings Beat
 - What is a Secondary Public Offering? What Investors Need to Know
 - Super Micro’s Moment of Truth: A Growth Story Under Pressure
 
Receive News & Ratings for ConvaTec Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConvaTec Group and related companies with MarketBeat.com's FREE daily email newsletter.
